The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults

Trial Profile

The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults

Completed
Phase of Trial: Phase II

Latest Information Update: 03 May 2018

At a glance

  • Drugs Mitoquinone (Primary)
  • Indications Unspecified
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 May 2018 Results presented in the MitoQ media release.
    • 03 May 2018 According to a MitoQ Ltd media release, results from this trial were published in the Hypertension.
    • 11 Apr 2018 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top